Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah M Dry

Showing results (141-150 of 144) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 144 results.
Biochemical and Biophysical Research Communications|September 1, 2018
Combination therapy of tumor-targeting Salmonella typhimurium A1-R and oral recombinant methioninase regresses a BRAF-V600E-negative melanomaKei Kawaguchi, Takashi Higuchi, Shukuan Li, et al.
Biochemical and Biophysical Research Communications|October 8, 2018
A combination of irinotecan/cisplatinum and irinotecan/temozolomide or tumor-targeting Salmonella typhimurium A1-R arrest doxorubicin- and temozolomide-resistant myxofibrosarcoma in a PDOX mouse modelTasuku Kiyuna, Yasunori Tome, Takashi Murakami, et al.
Journal of Surgical Oncology|July 9, 2025
Incomplete Cancer Surgery Correlates With Loss of Immune Surveillance and Hyper-Progression of DiseaseStuart A Fine, Sin Yee Lim, Nicholas M Siena, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2026
Toward the simultaneous detection of multiple diseases with a highly cost-effective cell-free DNA methylome testWeihua Zeng, Chun-Chi Liu, Shuo Li, et al.
Pageof 15

Showing results (141-150 of 144) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 144 results.
Biochemical and Biophysical Research Communications|September 1, 2018
Combination therapy of tumor-targeting Salmonella typhimurium A1-R and oral recombinant methioninase regresses a BRAF-V600E-negative melanomaKei Kawaguchi, Takashi Higuchi, Shukuan Li, et al.
Biochemical and Biophysical Research Communications|October 8, 2018
A combination of irinotecan/cisplatinum and irinotecan/temozolomide or tumor-targeting Salmonella typhimurium A1-R arrest doxorubicin- and temozolomide-resistant myxofibrosarcoma in a PDOX mouse modelTasuku Kiyuna, Yasunori Tome, Takashi Murakami, et al.
Journal of Surgical Oncology|July 9, 2025
Incomplete Cancer Surgery Correlates With Loss of Immune Surveillance and Hyper-Progression of DiseaseStuart A Fine, Sin Yee Lim, Nicholas M Siena, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2026
Toward the simultaneous detection of multiple diseases with a highly cost-effective cell-free DNA methylome testWeihua Zeng, Chun-Chi Liu, Shuo Li, et al.
Pageof 15